首页> 美国政府科技报告 >Breast Cancer-Targeted Nuclear Drug Delivery Overcoming Drug Resistance for Breast Cancer Chemotherapy.
【24h】

Breast Cancer-Targeted Nuclear Drug Delivery Overcoming Drug Resistance for Breast Cancer Chemotherapy.

机译:以乳腺癌为目标的核药物释放克服乳腺癌化疗的耐药性。

获取原文

摘要

Cell membrane-associated and intracellular drug resistance mechanisms are the major cause of breast cancer treatment failure. The aim of this proposal is to develop nuclear localizing nanoparticles to delivery DNA- toxins breast cancer cell nuclei to effectively overcoming the drug resistance. We finished the task 1 - To synthesize and optimize folic-acid- or LHRHfunctionalized charge reversal nanoparticles. The cationic polymer PEI and its block copolymer with degradable PCL were synthesized. The cationic PEI block amines were converted to acid labile amides to obtain the PCL-PEI/amide block copolymer. This polymer was used to fabricate the nanoparticles. The ideal nanoparticles with optimal sizes and acid-triggered negative-to-positive charge reversal properties were fabricated and characterized carefully. These nanoparticles will be characterized in vitro and in vivo.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号